Potassium citrate (also known as tripotassium citrate) is a potassium salt of citric acid. It is a white, hygroscopic crystalline powder. It is odorless with a saline taste. It contains 38.3% potassium by mass. In the monohydrate form it is highly hygroscopic and deliquescent.
Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. Potassium Citrate is indicated also for the management of Hypocitraturic calcium oxalate nephrolithiasis.
For the management of renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.
University of California, Irvine Medical Center, Orange, California, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Northwestern University, Chicago, Illinois, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
CHU Grenoble, Grenoble Cedex, France
Centre Hospitalier Universitaire de Lyon - Hôpital Femme Mère Enfant, Bron, France
CHU Purpan, Toulouse cedex 9, France
CHU Reims, Reims, France
UZ Leuven, Gasthuisberg Hospital, Leuven, Belgium
CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France
University of South Florida Pediatric Infectious Diseases, Tampa, Florida, United States
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
The Hospital for Sick Children, Toronto, Ontario, Canada
Children's Hospital Colorado, Aurora, Colorado, United States
Hospital Clínic de Barcelona, Barcelona, Spain
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.